BioSpace News Archive

IR-Med (OTC: IRME) (“Company” or “the Company”) is proud to announce a series of corporate updates to its investors regarding the medical, financial, and corporate status of the company.

CCT Research, known for its innovative approach to conducting clinical trials, has announced Jennifer Kocour as President.

Unique real-world data platform integrating proprietary, regulatory-grade, patient-generated health data.

Magnetic Insight has installed a localized magnetic theranostic system at Johns Hopkins University to support an National Institutes of Health-funded project to develop precision-guided magnetic fluid hyperthermia.

The article “Tracking adoptive T cell immunotherapy using magnetic particle imaging” has been published in the journal Nanotheranostics (2021, vol 5.). This promising research was concluded using the MOMENTUM™ imager from Magnetic Insight to track the T cells inside a mouse migrating to a brain tumor.

American Cancer Society’s (ACS) Cancer Facts & Figures 2022 report, released today, shows that the five-year survival rate for pancreatic cancer has increased from 10 to 11%.

Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics (MDx) company, today, unveiled its blueprint for the future during a presentation at the 40th annual J.P. Morgan Healthcare virtual Conference.

Vaxcyte, Inc. announced today that it has commenced an underwritten public offering of its common stock and pre-funded warrants.

Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, announced that the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines) for the treatment of breast cancer have been updated for 2022 and include two important changes involving neratinib (NERLYNX®).

DotLab, a molecular diagnostics company at the forefront of research and development in women’s health, announced that the Accreditation Committee of the College of American Pathologists has awarded accreditation to DotLab based on results of a recent inspection as part of the CAP’s Accreditation Programs.